Joseph F. Amaral

Joseph F. Amaral

Auto-generated profile, based on publicly available information

Joseph F. Amaral

Health Economics and Market Access, Ethicon Inc, Cincinnati, OH, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in OncoTargets and Therapy
Verified
Journal Article
Open access
MGMrudula B. Glassberg
Mrudula B. Glassberg
SGSudip Ghosh
Sudip Ghosh
JCJeffrey Clymer
Jeffrey Clymer
RQRana A. Qadeer
Rana A. Qadeer
NFNicole C. Ferko
Nicole C. Ferko
JAJoseph F. Amaral
Joseph F. Amaral
Percutaneous ablation techniques, including microwave ablation (MWA) and radiofrequency ablation (RFA), have become important minimally invasive treatment options for liver cancer. This systematic review compared MWA with RFA for treatment of liver cancer. The systematic review and meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A systematic search of MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials was conducted for randomized and observational studies published from 2006 onwards. A random-effects model was used for meta-analyses and local tumor progression (LTP), technique efficacy, overall survival (OS), disease-free survival (DFS), intrahepatic de novo lesions (IDL), extrahepatic metastases (EHM), length of stay (LOS), and complications were analyzed. Subgroup and sensitivity analyses were also conducted. Of 1379 studies identified, 28 randomized and observational studies met inclusion criteria. The main analysis demonstrated that LTP was significantly reduced by 30% with MWA versus RFA (RR=0.70; P=0.02) (all studies) and by 45% with MWA versus RFA (RR=0.55; P=0.007) (randomized studies only). There were no significant differences between MWA and RFA for other efficacy and safety outcomes. Higher frequency (2450 MHz) and larger tumor size (≥2.5 cm) are amongst variables that may be associated with improved outcomes for MWA. Sensitivity analyses were generally congruent with the main results. MWA is at least as safe and effective as RFA for treating liver cancer and demonstrated significantly reduced LTP rates. Future studies should assess time and costs associated with these two treatment modalities.

15 August 2006
Verified
Book Chapter
Closed access
JAJoseph Amaral
Joseph Amaral
MCMichael Caldwell
Michael Caldwell